Business Developments
May 17, 2021

Microlink PC to distribute NuroKor technology to 200 occupational health & disabled service providers

Published on: 
May 17, 2021
NuroKor Team
Published on: 
December 21, 2022

Microlink PC to distribute NuroKor technology to 200 occupational health & disabled service providers

New partnership launched to reduce absenteeism and help disabled workers under UK scheme to get a million people into employment

  • Occupational health & disabled services provider distributes technology to 200 assessors
  • NuroKor bioelectric technology will help support disabled people as they start work
  • Microlink staff with health conditions successfully trial NuroKor therapy 

Microlink PC, a global leader in education and assistive technology solutions, is offering cutting-edge technology from NuroKor BioElectronics to 200 disability assessors, in a bid to reduce absenteeism and help disabled people back to work.

The assessors support an estimated 70,000 disabled graduate students and employees annually through Government grant schemes, to enable them to continue with their studies or employment.

From May  2021, Microlink will be extending the solution to the employment work programmes, to help unemployed people with health conditions and disabilities, as part of the UK’s pledge to get an additional one million disabled people back to work by 2027. 

Operating across eight countries, NuroKor develops and produces state-of-the-art, wearable technology using bioelectric nerve, muscle and microcurrent stimulation to manage pain and recovery and optimise physical performance.

Scott Hurst, Microlink PC Facilities Manager

Multi-award winning Microlink  decided to partner with the technology pioneer after loaning its mibody devices to a selection of its 100-strong workforce. As well as seeing a reduction in sick leave and an increase in productivity, after regularly using the technology for six weeks, one member of staff with painful arthritis was able to stop using a wheelchair and crutches, return to cycling 70 miles a week and stop taking strong, opioid painkillers.

Facilities manager Scott, 43, from Southampton, said:

“Before trying the device, my arthritis was so bad that I would have to use crutches or a wheelchair to move around at work. The pain stopped me cycling to the office, walking and even going shopping, so it really impacted my life. After 4-6 weeks of using it, I could get back on my bike and life’s a lot easier now.”

Microlink UK CEO Dr Nassar Siabi, OBE, claims the technology could revolutionise treatment of musculoskeletal conditions among the UK’s workforce and significantly help to reduce the high rates of absenteeism due to pain and discomfort. He said:

“I invested in devices for team members who were struggling with debilitating health conditions. The results were overwhelmingly positive and the next step is to share the technology with those supporting people with disabilities and health conditions, so that people who wish to return to work, could benefit.”

Currently the only life science company of its kind, NuroKor’s technology is distributed across the  UK, Norway, France, US, Australia, New Zealand, Malaysia and Ireland and will this year be expanding its US market reach.

NuroKor founder and CEO Rick Rowan said: “We know how pain can significantly impact on a person’s quality of life, so I am delighted that our technology will be used to help support Microlink’s users back into employment, as well as providing them with more control over their own care.”  

And as more remote workers experience posture-related pain, the technology looks set to be an alternative solution for organisations wanting to better support their workforce and cut condition-related absence and sickness.

NuroKor mitouch device in office

Dr Siabi added: “We now have millions of people working from home and we want to help reduce the rising numbers of people experiencing pain caused by bad posture. Staff need to have an ergonomic workstation to reduce discomfort and need access to emerging technology such as NuroKor’s, then you stop work-induced pain from developing into a permanent problem.

“Organisations will need to be more proactive in the care of their remote workforces because this is how millions of us now work.”

Hampshire-based Microlink will also introduce the technology to around more than 40 health and safety leads from its client base, which includes some of the UK’s leading banks, broadcast companies, law firms, councils and pharmaceutical companies. Its workplace adjustment programme currently supports the disabled employees of organisations with a combined workforce of more than 1.4 million across the UK and internationally.

Dr Siabi said: “By introducing this type of technology, I believe that the majority of long-term absenteeism, which is caused by pain related conditions, could be avoided. Forward-thinking companies can then ensure their workforce remains safe from work-related injuries.”


About Microlink

Microlink’s workplace adjustment service, MiCase, is embraced as best practice for some of the UK’s largest corporations. From dyslexia to arthritis, to visual and hearing loss, Microlink assesses, advises, supplies tools, provides training and supports people to break down barriers caused by disability or a health condition. 

Learn more here

About NuroKor

UK healthtech start-up NuroKor BioElectronics was created by CEO Rick Rowan in 2018, who identified the immense potential of bioelectric technology as therapeutic electroceutical applications.

NuroKor’s users range from clinicians to everyday people suffering from an array of conditions - from arthritis to menopause, as well as more than 50 Olympians and elite athletes. The bioelectronic technology enables greater autonomy over a person’s own treatment and can reduce the need for medication. To find out more, visit: